Factors associated with the presence and intensity of ongoing symptoms in Long COVID 2025 Ring et al

Discussion in 'Psychosomatic research - ME/CFS and Long Covid' started by Andy, Apr 25, 2025 at 10:41 AM.

  1. Andy

    Andy Retired committee member

    Messages:
    23,732
    Location:
    Hampshire, UK
    Abstract

    Objective
    Identification of modifiable factors associated with symptom intensity among people seeking care for Post-Acute Sequelae of SARS-CoV-2 infection (PASC) could help guide the development of comprehensive, whole-person care pathways to alleviate symptoms irrespective of potential underlying pathophysiologies. We aimed to better define the key contributors to PASC, and sought the factors associated with PASC symptom presence and intensity.

    Methods
    In this cross-sectional study, 249 patients presenting for PASC care at a dedicated Post-COVID-19 clinic completed a standardized screening assessment prior to initial visit and evaluation by a general internist or nurse practitioner. We measured 46 symptoms based on the WHO’s Global COVID-19 Clinical Platform Case Report Form for Post COVID Condition and performed a factor analysis and item response theory based 2-parameter logistic model to develop a population-based t-score to measure PASC symptom presence and intensity (PASC-SPI). A multivariable linear regression analysis was used to assess factors associated with PASC-SPI, accounting for demographics, comorbidities, COVID-19 infection duration and severity, and mental health.

    Results
    Greater PASC-SPI was associated with greater symptoms of anxiety, a longer duration of COVID-19 infection, and hypercholesterolemia. Lower PASC-SPI was associated with older age, self-reported 1–3 units of alcohol per week, and self-reported clinician confirmation of COVID-19 diagnosis. Symptoms of anxiety accounted for a considerably higher proportion of variation in PASC-SPI than other variables.

    Conclusion
    Symptoms of anxiety were the strongest correlate of PASC-SPI, highlighting it as both a potential neuroinflammatory marker of PASC and a modifiable component of the illness. This emphasizes the need for comprehensive, whole person treatment strategies that integrate evidence-based interventions to address the multifaceted nature of PASC.

    Open access
     
  2. Utsikt

    Utsikt Senior Member (Voting Rights)

    Messages:
    2,437
    Location:
    Norway
    If alleviate symptoms means to convince them that there is no need to report having these symptoms, sure.
    Correlation isn’t causation. How did this get published?
    Anxiety as a neuroinflammatory marker?

    Why do I get the feeling that «modifiable» implies that the illness as a whole will improve if we get people to report less anxiety?
     
    Trish and MEMarge like this.
  3. rvallee

    rvallee Senior Member (Voting Rights)

    Messages:
    14,544
    Location:
    Canada
    <poop emoji>

    Ask useless questions, get useless non-answers.
    This is an entirely useless way of assessing this: https://www.hiv.uw.edu/page/mental-health-screening/gad-2. You could apply the same BS to muggings or home fires and find the same useless non-answer.

    They do feature some minimal discussion of how the abstract is likely misleading, but it didn't sway them from writing a wildly misleading abstract nonetheless:
    Say the line, Bart:
    A truly stupid number of past studies have done this and only ever conclude that more money should be sent their way. Future studies will not shine any light on this nonsense, because this is simply not something that can be reliably studied.
     
    Trish, livinglighter and Utsikt like this.

Share This Page